Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ann Med. 2022 Dec;54(1):830-836. doi: 10.1080/07853890.2022.2051069.
INTRODUCTION: Rapid antiretroviral therapy (ART) initiation can improve patient outcomes such as viral suppression and prevent new infections. However, not everyone who can start ART does so immediately. METHODS: We conducted a qualitative study to inform interventions supporting rapid initiation in the 'Test and Start' era. We purposively sampled 20 adult patients living with HIV and a previous gap in care from ten health facilities in Lusaka, Zambia for interviews. We inductively analysed transcripts using a thematic, narrative approach. In their narratives, seven participants discussed delaying ART initiation. RESULTS: Drawing on messages gleaned from facility-based counselling and community information, many cited greater fear of rapid sickness or death due to imperfect adherence or treatment side effects than negative health consequences due to delayed initiation. Participants described needing time to 'prepare' their minds for a lifetime treatment commitment. Concerns about inadvertent HIV status disclosure during drug collection discouraged immediate initiation, as did feeling healthy, and worries about the impact of ART initiation on relationship dynamics. CONCLUSION: Findings suggest that counselling messages should accurately communicate treatment risks, without perpetuating fear-based narratives about HIV. Identifying and managing patient-specific concerns and reasons for the 'need for time' may be important for supporting individuals to rapidly accept lifelong treatment.Key messagesFear-based adherence messaging in health facilities about the dangers of missing a treatment dose or changing the time when ART is taken contributes to Zambian patients' refusals of immediate ART initiationResponsive health systems that balance a stated need for time to accept one's diagnosis and prepare to embark on a lifelong treatment plan with interventions to identify and manage patient-specific treatment related fears and concerns may support more rapid ART initiationPerceived social stigma around HIV continues to be a significant challenge for treatment initiation.
引言:快速抗逆转录病毒治疗(ART)的启动可以改善患者的预后,如病毒抑制和预防新的感染。然而,并非每个可以开始 ART 的人都能立即开始。
方法:我们进行了一项定性研究,为“检测即启动”时代支持快速启动的干预措施提供信息。我们从赞比亚卢萨卡的十个卫生机构中有意选择了 20 名患有 HIV 且之前存在护理空白的成年患者进行访谈。我们使用主题式、叙事式方法对转录本进行归纳分析。在他们的叙述中,有 7 名参与者讨论了延迟启动 ART。
结果:根据从医疗机构咨询和社区信息中收集到的信息,许多人表示,由于不完美的依从性或治疗副作用,比由于延迟启动而导致的负面健康后果,他们更害怕快速生病或死亡。参与者描述了需要时间来为终身治疗承诺“做好准备”。担心在取药过程中无意中透露 HIV 状态,以及感觉自己健康、担心启动 ART 对关系动态的影响,阻碍了立即启动。
结论:研究结果表明,咨询信息应该准确传达治疗风险,而不会加剧对 HIV 的基于恐惧的叙述。识别和管理患者特定的关注和“需要时间”的原因,对于支持个人快速接受终身治疗可能很重要。
关键信息:卫生机构中关于错过一剂治疗药物或改变服用 ART 时间的危险的基于恐惧的依从性信息传递,导致赞比亚患者拒绝立即开始 ART 治疗。平衡了接受诊断和准备开始终身治疗计划的时间需求与识别和管理与患者特定的治疗相关恐惧和担忧的干预措施的响应性卫生系统,可能支持更快速地开始 ART 治疗。艾滋病毒带来的社会污名仍然是治疗启动的一个重大挑战。
AIDS Patient Care STDS. 2013-3-26
J Acquir Immune Defic Syndr. 2021-3-1